Unterstützung des Immunsystems

KPV

Preisspanne: 175,00 $ bis 240,00 $

Per vial
$17.50
10 vials per pack
Suggested retail
$52.50
3× markup · per vial
Kostenloser Versand bei Bestellungen über 2.000 $
  • Liefergarantie Kostenloser Nachversand, falls die Lieferung nicht ankommt
  • Reinheit ≥ 99 % Direkt vom Hersteller
  • Unabhängige Echtheitszertifikate COAs für dieses Produkt anzeigen →
  • Garantie auf Gutschriften Senden Sie uns ein beliebiges COA-Ergebnis und erhalten Sie eine Gutschrift

KPV — Lysine-Proline-Valine Anti-Inflammatory Tripeptide

KPV is a three-amino-acid peptide – Lysine-Proline-Valine – that forms the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). While the full alpha-MSH peptide is best known for pigmentation signaling, the KPV fragment retains most of alpha-MSH’s anti-inflammatory activity while losing its melanocortin-receptor agonism. That is why researchers use KPV on its own – it isolates the anti-inflammatory arm of alpha-MSH biology without the pigmentation or appetite effects.


Why the Tripeptide Form Matters

KPV is small enough to be absorbed intact through the PepT1 transporter in the intestinal epithelium, which is the reason oral-delivery studies exist for it (most peptides this short would simply be degraded). Once inside the cell, it is cited in literature as downregulating NF-kappaB signaling and suppressing pro-inflammatory cytokine release. It is one of the few peptides with a published profile covering injected, oral, and topical routes.

Studiengang Was es im Klartext bedeutet
PepT1 transporter (gut) Carries KPV intact through the intestinal wall – the reason oral studies exist
NF-kappaB signaling Downregulated; cited in most KPV anti-inflammatory literature
Mast cells and macrophages Reduced pro-inflammatory cytokine release in published in-vitro work

KPV vs BPC-157

These two show up together in a lot of gut-repair literature, so the distinction matters.

Peptid Primary pathway Most-studied application
KPV Anti-inflammatory (NF-kappaB suppression) Colitis models, skin inflammation, mast-cell regulation
BPC-157 Angiogenesis and tissue repair (VEGF, nitric-oxide) GI mucosa, tendon, ligament

Researchers pair them in some study designs (KPV + BPC-157 capsules appear in the published literature) because the mechanisms are non-overlapping – one suppresses inflammation, the other builds structural repair.


Forschungsanwendungen

KPV is used in studies examining:

  • Colitis and intestinal-inflammation models (including the PepT1 oral-absorption pathway)
  • Mast-cell and macrophage anti-inflammatory signaling
  • Skin-inflammation models (transdermal and topical delivery)
  • NF-kappaB-mediated cytokine suppression
  • Comparative repair-peptide study designs (KPV + BPC-157)
  • Delivery-route comparisons (injected, oral, transdermal)

Technische Daten

Format Gefriergetrocknetes Pulver
Reinheit ≥99%
Aliasnamen Lysine-Proline-Valine, Lys-Pro-Val, alpha-MSH (11-13) fragment
Verfügbare Größen 5 mg · 10 mg
Lagerung 2–8 °C ungeöffnet; mindestens 12 Monate haltbar
Verwendung Nur für Forschungszwecke – nicht zur Anwendung am Menschen

Rekonstitution

KPV arrives as a freeze-dried powder and is reconstituted with bacteriostatic water:

Gesamtmenge in mg im Fläschchen ÷ hinzugefügte Wassermenge in ml = mg pro ml

Beispiel: Eine 5-mg-Ampulle + 2 ml bakteriostatisches Wasser = 2,5 mg pro ml. Eine 10-mg-Ampulle + 2 ml = 5 mg pro ml.

Nach der Zubereitung bei 2–8 °C lagern und innerhalb von 28–30 Tagen verbrauchen.


Anmerkungen zum Protokoll

The following values are reference points extracted from published KPV research – not instructions. Because KPV has both injected and oral literature, published protocols vary by route.

  • Dose range reported in the literature: 250-500mcg per administration
  • Administration frequency in published studies: Once daily is the most commonly reported frequency
  • Study durations reported: 4-8 weeks for inflammation and mucosal-repair endpoints

Common Questions About KPV Research

What does KPV do in research?

It is most commonly studied as an anti-inflammatory signaling peptide. In published in-vitro and animal work it downregulates NF-kappaB, reduces pro-inflammatory cytokine release from mast cells and macrophages, and is absorbed intact through the PepT1 gut transporter – which is why it appears in colitis and intestinal-inflammation models.

How is KPV different from BPC-157?

They act through different pathways. KPV is an anti-inflammatory tripeptide that suppresses NF-kappaB signaling. BPC-157 is a 15-amino-acid peptide most closely associated with angiogenesis and structural tissue repair. The two are sometimes paired in gut-repair research designs because the mechanisms do not overlap.

Can KPV be taken orally in research?

Yes – KPV is one of the few peptides with published oral-absorption data, because the PepT1 transporter carries the tripeptide across the intestinal wall intact. Injected and transdermal delivery are also represented in the literature. Route selection in a study depends on the endpoint being measured.

Is KPV FDA approved?

No. KPV is not approved by the FDA for any human use. Every vial WWP ships is labeled and sold strictly for laboratory and research use only.

How is KPV stored?

Ungeöffnete Fläschchen werden bei 2–8 °C gelagert und sind mindestens 12 Monate haltbar. Nach der Rekonstitution mit bakteriostatischem Wasser wird die Lösung bei 2–8 °C aufbewahrt und innerhalb von 28–30 Tagen verbraucht.


Reinheitsgarantie

Jede Charge weist eine Reinheit von ≥99 % auf. Senden Sie uns ein Analysezertifikat einer unabhängigen Prüfstelle, und wir stellen Ihnen unabhängig vom Ergebnis eine Gutschrift aus.